HHLA2 and non-small cell lung carcinoma: Numerous studies have shown that HHLA2 is upregulated in non-small cell lung carcinoma (NSCLC) including squamous cell carcinoma, lung adenocarcinoma (LUAD), and pulmonary sarcomatoid carcinoma (PSC) [19,20,86,87,88].